"Accident and Disaster Rapid Recovery by Myself" Samsung Bio Achieves 'ISO22301'

Received Consecutive Crisis Management System Certifications for Plant 3 Following Plants 1 and 2

Inside Samsung Biologics Plant 3

[Asia Economy Reporter Choi Dae-yeol] Honda, which operated a complete vehicle factory in Thailand, scrapped all vehicles due to the 2011 flood. It is the largest overseas factory of Honda outside China, but production resumed just six months after the flood damage. Morgan Stanley's response during the September 11, 2001 terrorist attacks was quite the opposite. The company, headquartered in the World Trade Center which collapsed instantly, was able to operate normally from the next day. This is cited as an example demonstrating the importance of crisis management during peacetime.

The international standard for business continuity management systems, ISO22301, certifies that a company can minimize operational disruptions and resume normal business activities as soon as possible despite unexpected contingencies such as natural disasters, incidents, accidents, or technical failures. Samsung Biologics’ Plant 3, considered the world's largest biopharmaceutical factory, recently received this certification.

Following Plants 1 and 2, which were the first among domestic pharmaceutical and bio companies to be certified in 2018, the company’s entire production facilities have now been internationally recognized for continuity. Along with Plant 3, testing facilities and small-scale production facilities were also certified this time.

President Kim Tae-han of Samsung Biologics (from the left in the photo), Song Kyung-soo, BSI General Manager, and Mark Buttigieg, Economic Counselor at the British Embassy in Korea, are taking a commemorative photo after the 'ISO 22301' certificate award ceremony on the 19th.

Given the critical nature of process management in pharmaceuticals, the capability to produce and supply stably under any circumstances is directly linked to customer acquisition. This is the background behind Samsung Biologics, whose main business is biopharmaceutical contract manufacturing organization (CMO), investing heavily in crisis response systems.

Since the CMO business takes about three years from contract to actual production, multinational pharmaceutical companies and other customers of Samsung Biologics place great importance on this certification and crisis management systems. The company formed a task force (TF) with 39 members drawn from 32 departments and prepared through virtual training for this certification.

Mark Buttigieg, Economic Counsellor at the British Embassy in Korea, said at the certification award ceremony held on the 19th, "This certification will have a positive effect on the satisfaction of global pharmaceutical clients in the US, Europe, and elsewhere," adding, "It is good news not only for the company but also for patients worldwide." Kim Tae-han, CEO of Samsung Biologics, said, "Since the products we produce for our clients are directly related to patients' lives, we must guarantee stable supply under any crisis situation."

This content was produced with the assistance of AI translation services.